Stockscreener 앱 받기
26.32
1.54%
0.40
시장 영업 전:
26.36
0.04
+0.15%
전일 마감가:
$25.92
열려 있는:
$26.08
하루 거래량:
722.94K
Relative Volume:
0.67
시가총액:
$1.75B
수익:
$5.79M
순이익/손실:
$-199.61M
주가수익비율:
-8.7442
EPS:
-3.01
순현금흐름:
$-188.48M
1주 성능:
+1.23%
1개월 성능:
-1.50%
6개월 성능:
+29.34%
1년 성능:
-2.59%
1일 변동 폭
$25.05
$26.63
1주일 범위
$24.53
$26.63
52주 변동 폭
$14.40
$29.05
Celldex Therapeutics Inc Stock (CLDX) Company Profile
명칭
Celldex Therapeutics Inc
전화
908-200-7500
주소
53 FRONTAGE ROAD, HAMPTON
CLDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDX
Celldex Therapeutics Inc
|
26.32 | 1.72B | 5.79M | -199.61M | -188.48M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.00 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.45 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.23 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.74 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.93 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-10-13 | 개시 | Barclays | Underweight |
| 2025-04-28 | 개시 | Canaccord Genuity | Buy |
| 2025-03-20 | 개시 | Morgan Stanley | Overweight |
| 2025-02-13 | 개시 | UBS | Buy |
| 2024-10-07 | 개시 | Citigroup | Buy |
| 2024-09-30 | 개시 | Goldman | Neutral |
| 2024-09-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-18 | 개시 | Stifel | Buy |
| 2024-06-11 | 개시 | Wolfe Research | Outperform |
| 2023-12-20 | 개시 | TD Cowen | Outperform |
| 2023-11-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-08-22 | 개시 | Wells Fargo | Underweight |
| 2021-09-17 | 개시 | Jefferies | Buy |
| 2021-09-10 | 개시 | SVB Leerink | Outperform |
| 2021-07-22 | 개시 | Guggenheim | Buy |
| 2020-02-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-08-01 | 재개 | H.C. Wainwright | Buy |
| 2016-11-07 | 개시 | Aegis Capital | Buy |
| 2016-03-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2016-03-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2016-03-07 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
| 2016-03-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-01 | 개시 | H.C. Wainwright | Buy |
| 2015-08-11 | 재확인 | Brean Capital | Buy |
| 2015-08-11 | 재확인 | Oppenheimer | Outperform |
| 2015-08-11 | 재확인 | ROTH Capital | Buy |
| 2015-06-02 | 재확인 | WBB Securities | Strong Buy |
| 2014-11-17 | 재확인 | ROTH Capital | Buy |
| 2014-03-04 | 재확인 | Oppenheimer | Outperform |
| 2013-07-08 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-03-08 | 재확인 | Cantor Fitzgerald | Buy |
| 2013-02-26 | 재확인 | Oppenheimer | Outperform |
| 2013-01-10 | 재확인 | Cantor Fitzgerald | Buy |
| 2012-10-02 | 재확인 | Oppenheimer | Outperform |
| 2012-09-14 | 재확인 | Cantor Fitzgerald | Buy |
모두보기
Celldex Therapeutics Inc 주식(CLDX)의 최신 뉴스
Celldex Therapeutics Hits Day High with Strong 7.72% Intraday Surge - Markets Mojo
Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution - The Globe and Mail
Will Celldex Therapeutics Inc. (TCE2) stock see insider accumulationDip Buying & Reliable Entry Point Alerts - newser.com
Can Celldex Therapeutics Inc. (TCE2) stock reach $200 price targetGDP Growth & Verified Trade Idea Suggestions - newser.com
Why Celldex Therapeutics Inc. stock could be next big winnerRisk Management & Reliable Entry Point Trade Alerts - newser.com
Real time social sentiment graph for Celldex Therapeutics Inc.2025 Key Lessons & High Accuracy Investment Signals - newser.com
Celldex Therapeutics Hits Day High with 9.61% Surge in Stock Price - Markets Mojo
What risks investors should watch in Celldex Therapeutics Inc. stockWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
Celldex Therapeutics Inc. stock momentum explained2025 Sector Review & Low Risk High Reward Ideas - newser.com
Does Celldex Therapeutics Inc. qualify in momentum factor screening - newser.com
How to use a screener to detect Celldex Therapeutics Inc. breakoutsTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
What’s next for Celldex Therapeutics Inc. stock price2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
Can Celldex Therapeutics Inc. (TCE2) stock sustain revenue momentum2025 Analyst Calls & Reliable Trade Execution Plans - newser.com
Why Celldex Therapeutics Inc. (TCE2) stock is listed among top recommendations2025 Major Catalysts & Smart Allocation Stock Tips - newser.com
What momentum shifts mean for Celldex Therapeutics Inc.2025 Institutional Moves & Safe Swing Trade Setup Alerts - newser.com
Is Celldex Therapeutics Inc. stock a bargain at current levelsMarket Activity Recap & Weekly High Conviction Trade Ideas - newser.com
Visualizing Celldex Therapeutics Inc. stock with heatmapsAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com
Will Celldex Therapeutics Inc. (TCE2) stock outperform energy sector in 2025Quarterly Profit Review & Entry Point Confirmation Signals - newser.com
Is it too late to sell Celldex Therapeutics Inc.2025 Short Interest & Verified Short-Term Trading Plans - newser.com
Will Celldex Therapeutics Inc. (TCE2) stock hit Wall Street targetsWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Identifying reversal signals in Celldex Therapeutics Inc.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
Why Celldex Therapeutics Inc. stock is considered a top pickWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Celldex Therapeutics Inc (CLDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.13%
4.32%
자본화:
|
볼륨(24시간):